An alpha-synuclein that is encoded in the genome of human. [PRO:DNx, UniProtKB:P37840]
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
allantoin | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
[3-carboxy-2-(1-oxohexadecoxy)propyl]-trimethylammonium | Homo sapiens (human) | Potency | 25.9290 | 1 | 0 |
s,s'-1,4-phenylene-bis(1,2-ethanediyl)bis-isothiourea | Homo sapiens (human) | Potency | 20.5962 | 1 | 0 |
ro 5-4864 | Homo sapiens (human) | Potency | 11.2202 | 1 | 0 |
4,5,6,7-tetrabromo-2-azabenzimidazole | Homo sapiens (human) | Potency | 2.5929 | 1 | 0 |
p-chloromercuribenzoic acid | Homo sapiens (human) | Potency | 4.4836 | 1 | 0 |
phenanthridone | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
6-nitroso-1,2-benzopyrone | Homo sapiens (human) | Potency | 18.3564 | 1 | 0 |
8-cyclopentyl-1,3-dimethylxanthine | Homo sapiens (human) | Potency | 6.5131 | 1 | 0 |
oxyquinoline | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
abt 702 | Homo sapiens (human) | Potency | 20.5962 | 1 | 0 |
aurintricarboxylic acid | Homo sapiens (human) | Potency | 4.1095 | 1 | 0 |
benzbromarone | Homo sapiens (human) | Potency | 2.2387 | 1 | 0 |
benzo(b)thiophene-2-boronic acid | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
bay h 4502 | Homo sapiens (human) | Potency | 2.5119 | 1 | 0 |
calmidazolium | Homo sapiens (human) | Potency | 5.8048 | 1 | 0 |
cantharidin | Homo sapiens (human) | Potency | 4.6109 | 1 | 0 |
carmustine | Homo sapiens (human) | Potency | 18.3564 | 1 | 0 |
cetylpyridinium | Homo sapiens (human) | Potency | 14.1254 | 1 | 0 |
chloroxine | Homo sapiens (human) | Potency | 4.4668 | 1 | 0 |
clioquinol | Homo sapiens (human) | Potency | 4.0075 | 1 | 0 |
clofoctol | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
clotrimazole | Homo sapiens (human) | Potency | 0.6513 | 1 | 0 |
cloxyquin | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
dephostatin | Homo sapiens (human) | Potency | 19.3736 | 1 | 0 |
dequalinium | Homo sapiens (human) | Potency | 23.1093 | 1 | 0 |
dichlorophen | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
disulfiram | Homo sapiens (human) | Potency | 5.1735 | 1 | 0 |
doxazosin | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
ebastine | Homo sapiens (human) | Potency | 29.0929 | 1 | 0 |
ebselen | Homo sapiens (human) | Potency | 4.4780 | 1 | 0 |
ethion | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
felodipine | Homo sapiens (human) | Potency | 29.0929 | 1 | 0 |
flufenamic acid | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
flutamide | Homo sapiens (human) | Potency | 22.3872 | 1 | 0 |
gentian violet | Homo sapiens (human) | Potency | 11.2202 | 1 | 0 |
gossypol | Homo sapiens (human) | Potency | 6.7963 | 1 | 0 |
hexachlorophene | Homo sapiens (human) | Potency | 3.5481 | 1 | 0 |
hexestrol | Homo sapiens (human) | Potency | 19.9526 | 1 | 0 |
indirubin-3'-monoxime | Homo sapiens (human) | Potency | 2.5929 | 1 | 0 |
isoconazole | Homo sapiens (human) | Potency | 0.5623 | 1 | 0 |
itraconazole | Homo sapiens (human) | Potency | 2.2387 | 1 | 0 |
1-(2-naphthalenyl)-3-[(phenylmethyl)-propan-2-ylamino]-1-propanone | Homo sapiens (human) | Potency | 11.4782 | 1 | 0 |
lansoprazole | Homo sapiens (human) | Potency | 29.0929 | 1 | 0 |
beta-lapachone | Homo sapiens (human) | Potency | 22.3872 | 1 | 0 |
mequitazine | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
methoctramine | Homo sapiens (human) | Potency | 2.3109 | 1 | 0 |
moclobemide | Homo sapiens (human) | Potency | 3.9811 | 1 | 0 |
fenamic acid | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
nialamide | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
niclosamide | Homo sapiens (human) | Potency | 1.4137 | 1 | 0 |
niflumic acid | Homo sapiens (human) | Potency | 16.3601 | 1 | 0 |
oxaprozin | Homo sapiens (human) | Potency | 25.9290 | 1 | 0 |
pd 169316 | Homo sapiens (human) | Potency | 9.2000 | 1 | 0 |
pomiferin | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
ag 1879 | Homo sapiens (human) | Potency | 2.3753 | 1 | 0 |
ppm 18 | Homo sapiens (human) | Potency | 4.4668 | 1 | 0 |
promazine | Homo sapiens (human) | Potency | 4.4668 | 1 | 0 |
3-[(3,5-dibromo-4-hydroxyphenyl)methylidene]-5-iodo-1H-indol-2-one | Homo sapiens (human) | Potency | 3.1623 | 1 | 0 |
pf 5901 | Homo sapiens (human) | Potency | 26.9188 | 1 | 0 |
riluzole | Homo sapiens (human) | Potency | 11.5821 | 1 | 0 |
sanguinarine | Homo sapiens (human) | Potency | 32.2871 | 1 | 0 |
ACar 18-0 | Homo sapiens (human) | Potency | 20.5962 | 1 | 0 |
thiram | Homo sapiens (human) | Potency | 5.0119 | 1 | 0 |
triclosan | Homo sapiens (human) | Potency | 11.2202 | 1 | 0 |
tyrphostin a9 | Homo sapiens (human) | Potency | 1.9259 | 1 | 0 |
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole | Homo sapiens (human) | Potency | 22.8518 | 1 | 0 |
dehydroepiandrosterone | Homo sapiens (human) | Potency | 2.2387 | 1 | 0 |
azauridine | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
pentylenetetrazole | Homo sapiens (human) | Potency | 6.5131 | 1 | 0 |
methylene blue | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
cycloheximide | Homo sapiens (human) | Potency | 1.5849 | 1 | 0 |
medroxyprogesterone acetate | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
n,n'-diphenyl-4-phenylenediamine | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
tetrabromobisphenol a | Homo sapiens (human) | Potency | 8.9125 | 1 | 0 |
quinophthalone | Homo sapiens (human) | Potency | 3.9811 | 1 | 0 |
quinoline | Homo sapiens (human) | Potency | 3.9811 | 1 | 0 |
1,2-diaminobenzene | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
fentichlor | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
methylenebis(chloroaniline) | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
triclocarban | Homo sapiens (human) | Potency | 0.8155 | 1 | 0 |
benzethonium chloride | Homo sapiens (human) | Potency | 22.3872 | 1 | 0 |
sulfan blue | Homo sapiens (human) | Potency | 11.2202 | 1 | 0 |
4-nitrosodimethylaniline | Homo sapiens (human) | Potency | 17.7828 | 1 | 0 |
sterogenol | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
diphenhydramine hydrochloride | Homo sapiens (human) | Potency | 3.5481 | 1 | 0 |
lithocholic acid | Homo sapiens (human) | Potency | 5.0119 | 1 | 0 |
kokusaginine | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
dibromsalicil | Homo sapiens (human) | Potency | 0.8913 | 1 | 0 |
dazomet | Homo sapiens (human) | Potency | 2.8184 | 1 | 0 |
evernic acid | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
nitrophenide | Homo sapiens (human) | Potency | 3.9811 | 1 | 0 |
isoxsuprine hydrochloride | Homo sapiens (human) | Potency | 2.8184 | 1 | 0 |
pentabromophenol | Homo sapiens (human) | Potency | 2.5119 | 1 | 0 |
3,4,5-trichlorophenol | Homo sapiens (human) | Potency | 11.2202 | 1 | 0 |
2'-deoxy-5'-adenosine monophosphate | Homo sapiens (human) | Potency | 14.1254 | 1 | 0 |
indole-3-acetic acid ethyl ester | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
2-amino-7-nitrofluorene | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
dehydroepiandrosterone acetate | Homo sapiens (human) | Potency | 11.2202 | 1 | 0 |
carmine | Homo sapiens (human) | Potency | 11.2202 | 1 | 0 |
pregnenolone carbonitrile | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
bisphenol a-glycidyl methacrylate | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
tetrachloroisophthalonitrile | Homo sapiens (human) | Potency | 1.4125 | 1 | 0 |
2,4-diacetylphloroglucinol | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
azaribine | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
ethyl violet | Homo sapiens (human) | Potency | 2.5119 | 1 | 0 |
2-amino-2',5-dichlorobenzophenone | Homo sapiens (human) | Potency | 19.9526 | 1 | 0 |
n-(4-dimethylamino-3,5-dinitrophenyl)maleimide | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
nitroxoline | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
1,6-bismaleimidohexane | Homo sapiens (human) | Potency | 6.3096 | 1 | 0 |
2,3,4,5-tetrachlorophenate | Homo sapiens (human) | Potency | 7.0795 | 1 | 0 |
fenestrel | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
clioxanide | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
n-(cyclohexylthio)phthalimide | Homo sapiens (human) | Potency | 14.1254 | 1 | 0 |
cetyldimethylethylammonium bromide | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
ursodeoxycholic acid | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
(7S,9S)-7-[(4-amino-5-hydroxy-6-methyl-2-oxanyl)oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
2-n-octyl-4-isothiazolin-3-one | Homo sapiens (human) | Potency | 3.9811 | 1 | 0 |
enilconazole | Homo sapiens (human) | Potency | 3.5481 | 1 | 0 |
wr 171,699 | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
isovelleral | Homo sapiens (human) | Potency | 6.3096 | 1 | 0 |
triadimefon | Homo sapiens (human) | Potency | 1.1220 | 1 | 0 |
lonidamine | Homo sapiens (human) | Potency | 29.0929 | 1 | 0 |
Nanaomycin | Homo sapiens (human) | Potency | 0.3548 | 1 | 0 |
nicardipine hydrochloride | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
triadimenol | Homo sapiens (human) | Potency | 0.3548 | 1 | 0 |
triclabendazole | Homo sapiens (human) | Potency | 1.9953 | 1 | 0 |
azelastine hydrochloride | Homo sapiens (human) | Potency | 22.3872 | 1 | 0 |
mibefradil | Homo sapiens (human) | Potency | 29.0929 | 1 | 0 |
duloxetine hydrochloride | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
sudan black b | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
daunorubicin hydrochloride | Homo sapiens (human) | Potency | 4.4668 | 1 | 0 |
xanthyletine | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
epirubicin hydrochloride | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
17 beta-estradiol hemisuccinate | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
meconin | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
miconazole nitrate | Homo sapiens (human) | Potency | 17.7828 | 1 | 0 |
econazole nitrate | Homo sapiens (human) | Potency | 0.5623 | 1 | 0 |
sanguinarine chloride | Homo sapiens (human) | Potency | 39.8107 | 1 | 0 |
bithionol sulfoxide | Homo sapiens (human) | Potency | 7.9433 | 1 | 0 |
2,6-di-tert-butyl-4-nitrophenol | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
2,3,4-trihydroxbenzophenone | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
2,2',2''-terpyridine | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
masoprocol | Homo sapiens (human) | Potency | 29.0929 | 1 | 0 |
3-octadecanamido-2-ethoxypropylphosphocholine | Homo sapiens (human) | Potency | 29.0929 | 1 | 0 |
honokiol | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
methyl fluorone black | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
1,10-phenanthroline-5,6-dione | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
2-chloranil | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
amperozide hydrochloride | Homo sapiens (human) | Potency | 22.3872 | 1 | 0 |
n-benzylmaleimide | Homo sapiens (human) | Potency | 17.7828 | 1 | 0 |
Oroselone | Homo sapiens (human) | Potency | 5.0119 | 1 | 0 |
2-phenylisatogen | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
4-(2-thiazolylazo)resorcinol | Homo sapiens (human) | Potency | 2.2387 | 1 | 0 |
2-methyl-4-nitroquinoline 1-oxide | Homo sapiens (human) | Potency | 3.9811 | 1 | 0 |
2-(carboxymethylthio)benzothiazole | Homo sapiens (human) | Potency | 17.7828 | 1 | 0 |
8-(4-tolylsulfonylamino)quinoline | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
n-(4-(2-benzoxazolyl)phenyl)maleimide | Homo sapiens (human) | Potency | 4.4668 | 1 | 0 |
fluazinam | Homo sapiens (human) | Potency | 1.7783 | 1 | 0 |
1-(2-thiazolylazo)-2-naphthol | Homo sapiens (human) | Potency | 7.9433 | 1 | 0 |
cortisol octanoate | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
bnps-skatole | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
efuamide | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
diffractaic acid | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
ska-31 | Homo sapiens (human) | Potency | 2.5119 | 1 | 0 |
1-phenazinecarboxylic acid | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
phellopterin | Homo sapiens (human) | Potency | 14.1254 | 1 | 0 |
3-[3-(trifluoromethyl)phenyl]-1-methylurea | Homo sapiens (human) | Potency | 17.7828 | 1 | 0 |
zpck | Homo sapiens (human) | Potency | 12.5009 | 1 | 0 |
2-(3'-methoxy-4'-hydroxybenzylidene)cyclopentene-1,3-dione | Homo sapiens (human) | Potency | 1.0000 | 1 | 0 |
alphaxalone | Homo sapiens (human) | Potency | 25.9290 | 1 | 0 |
cp-55,940 | Homo sapiens (human) | Potency | 20.3274 | 1 | 0 |
cv 3988 | Homo sapiens (human) | Potency | 29.0929 | 1 | 0 |
Zearalanone | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
1-(carboxymethylthio)tetradecane | Homo sapiens (human) | Potency | 29.0929 | 1 | 0 |
pd 128042 | Homo sapiens (human) | Potency | 14.1254 | 1 | 0 |
glabridin | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
1-(2-hydroxyethyl)-3,5-diphenyl-1h-pyrazole | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
omeprazole magnesium | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
n-(6-methoxy-8-quinolyl)-4-toluenesulfonamide | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
4,8-dimethyl-5'-carboxypsoralen | Homo sapiens (human) | Potency | 11.2202 | 1 | 0 |
2-chloroacetoacetanilide | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
2-methyl-4-(phenylimino)naphth(2,3-d)oxazol-9-one | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
8-(4-benzenesulfonylamino)quinoline | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
2-phenyl-1,2-benzisothiazol-3-(2h)-one | Homo sapiens (human) | Potency | 22.3872 | 1 | 0 |
barbatic acid | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
17 alpha-hydroxyprogesterone caproate | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
abt 980 | Homo sapiens (human) | Potency | 32.2871 | 1 | 0 |
chrysomycin b | Homo sapiens (human) | Potency | 6.3096 | 1 | 0 |
nbi 27914 | Homo sapiens (human) | Potency | 16.3601 | 1 | 0 |
sorafenib | Homo sapiens (human) | Potency | 8.9125 | 1 | 0 |
1-Anilino-9,10-dioxo-2-anthroic acid | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
erythritol | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
2-carbazol-9-ylbenzoic acid | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
N-tert-butyl-6-ethyl-1-phenyl-4-pyrazolo[3,4-d]pyrimidinamine | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
adrenosterone | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
acetoxycycloheximide | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
2-pyridin-4-yl-1,3-benzothiazole | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
1-benzothiophen-2-yl-(4-dimethylaminophenyl)methanol | Homo sapiens (human) | Potency | 14.1254 | 1 | 0 |
anisomycin | Homo sapiens (human) | Potency | 28.1838 | 1 | 0 |
gardenin a | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
nsc 95397 | Homo sapiens (human) | Potency | 19.5464 | 1 | 0 |
1-phenyl-3-(3,4,5-trimethoxyphenyl)-2-propen-1-one | Homo sapiens (human) | Potency | 22.3872 | 1 | 0 |
nsc-126771 | Homo sapiens (human) | Potency | 5.0119 | 1 | 0 |
brusatol | Homo sapiens (human) | Potency | 28.1838 | 1 | 0 |
wortmannin | Homo sapiens (human) | Potency | 5.0119 | 1 | 0 |
nsc228155 | Homo sapiens (human) | Potency | 0.5623 | 1 | 0 |
rocaglamide | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
2,3-dichloro-5,8-dimethoxy-1,4-naphthoquinone | Homo sapiens (human) | Potency | 2.8184 | 1 | 0 |
nsc 680410 | Homo sapiens (human) | Potency | 19.9526 | 1 | 0 |
nexavar | Homo sapiens (human) | Potency | 17.7828 | 1 | 0 |
1-methoxy-10H-acridin-9-one | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
9-deazaadenosine | Homo sapiens (human) | Potency | 11.2202 | 1 | 0 |
tosylphenylalanyl chloromethyl ketone | Homo sapiens (human) | Potency | 16.3601 | 1 | 0 |
beta-chloro-l-alanine | Homo sapiens (human) | Potency | 9.2000 | 1 | 0 |
epiandrosterone | Homo sapiens (human) | Potency | 3.9811 | 1 | 0 |
doxorubicin hydrochloride | Homo sapiens (human) | Potency | 4.4668 | 1 | 0 |
roxithromycin | Homo sapiens (human) | Potency | 6.3096 | 1 | 0 |
mycophenolic acid | Homo sapiens (human) | Potency | 7.0795 | 1 | 0 |
5,11-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol | Homo sapiens (human) | Potency | 18.3564 | 1 | 0 |
t0901317 | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
adenosine-5'-(n-ethylcarboxamide) | Homo sapiens (human) | Potency | 28.1838 | 1 | 0 |
diethylstilbestrol | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
ketoconazole | Homo sapiens (human) | Potency | 3.4437 | 1 | 0 |
meso-dihydroguaiaretic acid | Homo sapiens (human) | Potency | 17.7828 | 1 | 0 |
glyasperin D | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
4-(2-oxazolo[4,5-b]pyridinyl)aniline | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
8-isopentenylnaringenin | Homo sapiens (human) | Potency | 19.9526 | 1 | 0 |
IPA-3 | Homo sapiens (human) | Potency | 7.3078 | 1 | 0 |
2-sulfanylidene-1,3-dithiole-4,5-dicarboxylic acid dimethyl ester | Homo sapiens (human) | Potency | 17.7828 | 1 | 0 |
4-(4-chloro-2-methylphenoxy)-n-hydroxybutanamide | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
4-chloro-N-(4-chloro-2,5-dimethoxyphenyl)-5-dithiazolimine | Homo sapiens (human) | Potency | 7.5060 | 1 | 0 |
5-(4-nitrophenyl)-4-phenyl-2-thiazolamine | Homo sapiens (human) | Potency | 2.8184 | 1 | 0 |
idarubicin hydrochloride | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
pirarubicin hydrochloride | Homo sapiens (human) | Potency | 28.1838 | 1 | 0 |
niflumic acid | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
isoliquiritigenin | Homo sapiens (human) | Potency | 32.6427 | 1 | 0 |
xanthoangelol | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
calmidazolium | Homo sapiens (human) | Potency | 16.8037 | 1 | 0 |
9-methyl-6H-benzo[c][1,2]benzothiazine 5,5-dioxide | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
5-hydroxy-N,N-dimethyl-2-phenyl-3-benzofurancarboxamide | Homo sapiens (human) | Potency | 22.3872 | 1 | 0 |
N-(4-fluorophenyl)-3-[(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)thio]propanamide | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
2-amino-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d][1,3]thiazin-4-one | Homo sapiens (human) | Potency | 2.2387 | 1 | 0 |
N-[2-[(3-cyano-6-ethoxy-2-quinolinyl)amino]ethyl]propanamide | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
N-(4-chlorophenyl)-3-[(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)thio]propanamide | Homo sapiens (human) | Potency | 1.9953 | 1 | 0 |
2-acetyl-6-amino-8-(2-phenylethyl)-1,3,8,8a-tetrahydroisoquinoline-5,7,7-tricarbonitrile | Homo sapiens (human) | Potency | 6.3096 | 1 | 0 |
N-(4-methylphenyl)-2-(3-oxo-5,6-dihydroimidazo[2,1-b]thiazol-2-yl)acetamide | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
N-cyclopropyl-4-(2,3-dihydroindol-1-ylsulfonyl)benzenesulfonamide | Homo sapiens (human) | Potency | 17.7828 | 1 | 0 |
1-(4-chlorophenyl)-N-(2-furanylmethyl)-N-[[1-(2-methylbutan-2-yl)-5-tetrazolyl]methyl]methanamine | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
3-chloro-4-[4-(4-fluorophenyl)sulfonyl-1-piperazinyl]-N,N-dimethylbenzenesulfonamide | Homo sapiens (human) | Potency | 3.9811 | 1 | 0 |
2-[(2-cyclohexyl-4-quinazolinyl)thio]-N-(4-methyl-1,2,5-oxadiazol-3-yl)acetamide | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
1-phenyl-4-[[1-(phenylmethyl)-5-tetrazolyl]-(3-pyridinyl)methyl]piperazine | Homo sapiens (human) | Potency | 7.0795 | 1 | 0 |
1-[(1-cyclopentyl-5-tetrazolyl)-thiophen-2-ylmethyl]-4-(2-methoxyphenyl)piperazine | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
cefsulodin sodium | Homo sapiens (human) | Potency | 56.2341 | 1 | 0 |
iaa 94 | Homo sapiens (human) | Potency | 29.0929 | 1 | 0 |
N-[4-(4-fluorophenyl)-2-thiazolyl]-2-[(4-methylphenyl)sulfonylamino]benzamide | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
methamilane methiodide | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]-3,3,3-trifluoro-2-methyl-2-(trifluoromethyl)propanamide | Homo sapiens (human) | Potency | 19.9526 | 1 | 0 |
N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]-2,2-bis(trifluoromethyl)butanamide | Homo sapiens (human) | Potency | 17.7828 | 1 | 0 |
5-bromo-3-ethyl-1H-indole-2-carboxylic acid | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
N-(3-methoxyphenyl)-5-oxo-6,7-dihydro-[1,2,4]triazolo[3,4-b][1,3]thiazine-7-carboxamide | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
1-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-yl)ethanol | Homo sapiens (human) | Potency | 22.3872 | 1 | 0 |
1-(2,1,3-benzoxadiazol-4-yloxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)-2-butanone | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
1-[1-(3-fluorophenyl)-2,5-dioxo-3-pyrrolidinyl]-4-piperidinecarboxamide | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
N-[2-[5-[(2,4-dichlorophenyl)methylsulfonyl]-1,3,4-oxadiazol-2-yl]ethyl]carbamic acid tert-butyl ester | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
5-(3-chlorophenyl)-N-[2-methyl-5-(3-methyl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazol-6-yl)phenyl]-2-furancarboxamide | Homo sapiens (human) | Potency | 4.4668 | 1 | 0 |
dienestrol | Homo sapiens (human) | Potency | 7.0795 | 1 | 0 |
4-cyclohexyl-3-[(3-methylphenoxy)methyl]-1H-1,2,4-triazole-5-thione | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
3,4-methylenedioxy-beta-nitrostyrene | Homo sapiens (human) | Potency | 5.8048 | 1 | 0 |
(e)-3-(4-t-butylphenyl)-n-(2,3-dihydrobenzo(b)(1,4)dioxin-6-yl)acrylamide | Homo sapiens (human) | Potency | 8.1995 | 1 | 0 |
sch-202676 | Homo sapiens (human) | Potency | 22.2720 | 1 | 0 |
4-methoxy-N-(3-pyridinylmethyl)benzamide | Homo sapiens (human) | Potency | 19.9526 | 1 | 0 |
3-(4-methylbenzoyl)acrylic acid | Homo sapiens (human) | Potency | 3.1623 | 1 | 0 |
N4-(3-chlorophenyl)-6-methyl-N2-(phenylmethyl)pyrimidine-2,4-diamine | Homo sapiens (human) | Potency | 14.1254 | 1 | 0 |
n-phenyl-n'-2-pyridylthiourea | Homo sapiens (human) | Potency | 14.1254 | 1 | 0 |
4-chloro-1-methyl-3-nitro-2-quinolinone | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
4-[(4-chloro-5-dithiazolylidene)amino]benzonitrile | Homo sapiens (human) | Potency | 7.8435 | 1 | 0 |
4-chloro-N-(3,4,5-trimethoxyphenyl)-5-dithiazolimine | Homo sapiens (human) | Potency | 2.8184 | 1 | 0 |
10-methyl-3-phenothiazinamine | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
vu0038882 | Homo sapiens (human) | Potency | 2.2387 | 1 | 0 |
2-(thiophen-2-ylmethylidene)indene-1,3-dione | Homo sapiens (human) | Potency | 3.1623 | 1 | 0 |
N-[4-(3,4-dimethylphenyl)-2-thiazolyl]-2-furancarboxamide | Homo sapiens (human) | Potency | 8.9125 | 1 | 0 |
5-amino-3-(4-methoxyphenyl)-7-methyl-4-oxo-1-thieno[3,4-d]pyridazinecarboxylic acid methyl ester | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
1-(4-methoxyphenyl)-3-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)urea | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
2,4,6-trimethyl-n-(meta-3-trifluoromethylphenyl)benzenesulfonamide | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
1-(3-nitrophenyl)-3-phenyl-2-propyn-1-one | Homo sapiens (human) | Potency | 3.1623 | 1 | 0 |
N-[4-(2-methyl-4-thiazolyl)phenyl]benzamide | Homo sapiens (human) | Potency | 7.9433 | 1 | 0 |
5-ethyl-3-[[4-(2-methylpropoxy)phenyl]methylthio]-1H-1,2,4-triazole | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
4-chloro-1-ethyl-3-nitro-2-quinolinone | Homo sapiens (human) | Potency | 3.9811 | 1 | 0 |
3,5-dimethyl-1-[(7-methyl-2-naphthalenyl)sulfonyl]pyrazole | Homo sapiens (human) | Potency | 11.2202 | 1 | 0 |
5-(4-chlorophenyl)-2-furanpropionic acid | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
N-(4-fluorophenyl)-3,4-dihydro-1H-isoquinoline-2-carboxamide | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
N-(4-methylphenyl)carbamic acid (cyclopentylideneamino) ester | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
4-[(4-chlorophenyl)thio]-5-methyl-2-phenyl-1H-pyrazol-3-one | Homo sapiens (human) | Potency | 22.3872 | 1 | 0 |
N-(4-methoxyphenyl)-3-methyl-1,3-benzothiazol-2-imine | Homo sapiens (human) | Potency | 6.3096 | 1 | 0 |
4-chloro-3-ethoxy-N-(4-ethylphenyl)benzenesulfonamide | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
5-methyl-1-phenyl-4-pyrazolecarboxylic acid (4-methoxyphenyl) ester | Homo sapiens (human) | Potency | 3.5481 | 1 | 0 |
6-amino-2-mercaptobenzothiazole | Homo sapiens (human) | Potency | 8.9125 | 1 | 0 |
n-phenyl-n'-3-hydroxyphenylthiourea | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
5-(3,3-dimethyl-2-oxobutoxy)-4-ethyl-7-methyl-1-benzopyran-2-one | Homo sapiens (human) | Potency | 3.5481 | 1 | 0 |
2-(4-chlorophenyl)-N-[(2-hydroxy-5-methylanilino)-sulfanylidenemethyl]acetamide | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
7,8-dichloropyrido[1,2-a]benzimidazole | Homo sapiens (human) | Potency | 7.0795 | 1 | 0 |
N-[5-[(4-chlorophenoxy)methyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide | Homo sapiens (human) | Potency | 19.9526 | 1 | 0 |
curcumin | Homo sapiens (human) | Potency | 18.8541 | 1 | 0 |
4-(2-naphthalenyloxymethyl)-2-thiazolamine | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
1-(4-bromophenyl)-3-(2-fluorophenyl)thiourea | Homo sapiens (human) | Potency | 11.2202 | 1 | 0 |
1-(3,4-dichlorophenyl)-3-(3,5-dimethylphenyl)thiourea | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
2,3,5,6-tetramethyl-N-(2-methyl-1,3-benzothiazol-5-yl)benzenesulfonamide | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
2-[(1,5-diphenyl-2-imidazolyl)thio]-N-(2-furanylmethyl)acetamide | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
3-(n-benzylsulfamoyl)-4-bromo-n-(4-bromophenyl)benzamide | Homo sapiens (human) | Potency | 0.5623 | 1 | 0 |
2-[2-oxo-2-(2,2,4,6-tetramethyl-1-quinolinyl)ethyl]isoindole-1,3-dione | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
n-(1,3-benzothiazol-2-yl)-n-(4,5-dihydro-1h-imidazol-2-yl)amine | Homo sapiens (human) | Potency | 19.9526 | 1 | 0 |
N'-[2-(4-bromo-2-methylphenoxy)-1-oxoethyl]-2-pyrazinecarbohydrazide | Homo sapiens (human) | Potency | 22.3872 | 1 | 0 |
2-[[(5-ethyl-2-thiophenyl)-oxomethyl]amino]-4-methyl-5-thiazolecarboxylic acid ethyl ester | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
N-(5-tert-butyl-2-methoxyphenyl)-3,5-dimethyl-4-isoxazolecarboxamide | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
N-[5-[(4-chlorophenoxy)methyl]-1,3,4-thiadiazol-2-yl]-5-methyl-3-phenyl-4-isoxazolecarboxamide | Homo sapiens (human) | Potency | 6.3096 | 1 | 0 |
darunavir ethanolate | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
1-(4-bromophenyl)-3-(3-methylbutyl)thiourea | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
N-[[5-(1H-benzimidazol-2-yl)-2-methylanilino]-sulfanylidenemethyl]-5-chloro-2-methoxybenzamide | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
N-[3-(1,3-benzothiazol-2-ylthio)-4-hydroxyphenyl]-4-chlorobenzenesulfonamide | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
2-[(3-bromo-2-imidazo[1,2-a]pyrimidinyl)methylthio]-1,3-benzothiazole | Homo sapiens (human) | Potency | 19.9526 | 1 | 0 |
2-[[[5-(5,6-dimethyl-1H-benzimidazol-2-yl)-2-pyridinyl]thio]methyl]benzonitrile | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
8,9-dimethyl-N-(3-methylphenyl)-3-[2-(4-morpholinyl)ethyl]-4H-[1,3]thiazino[6,5-b]quinolin-2-imine | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
2-[(2-tert-butyl-4-quinazolinyl)thio]-N-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)acetamide | Homo sapiens (human) | Potency | 7.9433 | 1 | 0 |
5-tert-butyl-N-[2-(cyclopentylamino)-2-oxoethyl]-N-(2,5-dimethylphenyl)-3-methyl-2-furancarboxamide | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
4-chloro-N-(4-chloro-2-methylphenyl)-5-dithiazolimine | Homo sapiens (human) | Potency | 2.8184 | 1 | 0 |
4-[(2-chloro-5-thiazolyl)methylthio]benzoic acid | Homo sapiens (human) | Potency | 7.0795 | 1 | 0 |
N,N-dimethylcarbamic acid [4-[2-(4-fluorophenyl)sulfonyl-1-oxoethyl]-2,6-dimethylphenyl] ester | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
(4-chlorophenyl)-[4-[[(2,4-dichlorophenyl)thio]methyl]-4-hydroxy-1-piperidinyl]methanone | Homo sapiens (human) | Potency | 17.7828 | 1 | 0 |
6-fluoro-2-phenyl-1,2-benzothiazol-3-one | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
6-fluoro-2-(2-methylphenyl)-1,2-benzothiazol-3-one | Homo sapiens (human) | Potency | 11.2202 | 1 | 0 |
2-chloro-1-[1-(2-furanylmethyl)-2,5-dimethyl-3-pyrrolyl]ethanone | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
enclomiphene | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
n-(fluorenyl-9-methoxycarbonyl)leucine | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
4-methyl-N-[(1-oxopentylhydrazo)-sulfanylidenemethyl]benzamide | Homo sapiens (human) | Potency | 3.5481 | 1 | 0 |
5-[diethylamino(oxo)methyl]-4-methyl-2-(1-oxopentylamino)-3-thiophenecarboxylic acid methyl ester | Homo sapiens (human) | Potency | 11.2202 | 1 | 0 |
N-[[[2-(2-methoxyphenoxy)-1-oxoethyl]hydrazo]-sulfanylidenemethyl]-2-furancarboxamide | Homo sapiens (human) | Potency | 2.5119 | 1 | 0 |
N-[[[(2-methylphenyl)-oxomethyl]hydrazo]-sulfanylidenemethyl]benzamide | Homo sapiens (human) | Potency | 4.4668 | 1 | 0 |
3-(3-hydroxypropylamino)-7-methyl-1-(pentylamino)-6,8-dihydro-5H-2,7-naphthyridine-4-carbonitrile | Homo sapiens (human) | Potency | 3.5481 | 1 | 0 |
2-amino-4-[[2-(4-bromophenyl)-2-oxoethyl]thio]-3-azaspiro[5.5]undeca-1,4-diene-1,5-dicarbonitrile | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
N-bis(2-fluorophenoxy)phosphoryl-3,4-dimethylaniline | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
5-methyl-3-[(4-pentoxyphenyl)methylthio]-1H-1,2,4-triazole | Homo sapiens (human) | Potency | 3.5481 | 1 | 0 |
N-(4,5-diphenyl-2-oxazolyl)-3-methoxybenzamide | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
N-[2-(3,4-dimethoxyphenyl)ethyl]-8-ethoxy-5H-pyrimido[5,4-b]indol-4-amine | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
3-(1-benzotriazolylmethyl)-6-phenyl-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole | Homo sapiens (human) | Potency | 22.3872 | 1 | 0 |
2-tert-butyl-4-[(4-chlorophenyl)thio]-5-methyl-1H-pyrazol-3-one | Homo sapiens (human) | Potency | 6.3096 | 1 | 0 |
N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-4-[(4-methyl-1-piperidinyl)sulfonyl]benzamide | Homo sapiens (human) | Potency | 17.7828 | 1 | 0 |
N-(5-tert-butyl-2-phenyl-3-pyrazolyl)-2-[(6-methyl-1H-benzimidazol-2-yl)thio]acetamide | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
N-(5-cyclopropyl-1,3,4-thiadiazol-2-yl)-2,5-diphenyl-3-pyrazolecarboxamide | Homo sapiens (human) | Potency | 7.9433 | 1 | 0 |
2-chloro-N-(2-phenyl-5-propyl-3-pyrazolyl)acetamide | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
2-methyl-3-[oxo(thiophen-2-yl)methyl]-1-indolizinecarboxaldehyde | Homo sapiens (human) | Potency | 11.2202 | 1 | 0 |
6-[1-oxo-2-[[4-(phenylmethyl)-5-thiophen-2-yl-1,2,4-triazol-3-yl]thio]ethyl]-4H-1,4-benzoxazin-3-one | Homo sapiens (human) | Potency | 6.3096 | 1 | 0 |
N-[3-(6-methyl-4-phenyl-2-quinolinyl)phenyl]methanesulfonamide | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
4-(dipropylsulfamoyl)-N-[5-[(methylthio)methyl]-1,3,4-oxadiazol-2-yl]benzamide | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
4-[butyl(methyl)sulfamoyl]-N-[5-[(methylthio)methyl]-1,3,4-oxadiazol-2-yl]benzamide | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
4-[ethyl-(phenylmethyl)sulfamoyl]-N-(5-methyl-1,3,4-oxadiazol-2-yl)benzamide | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
1-[2-(2,5-dimethyl-1H-indol-3-yl)ethyl]-3-methyl-1-(thiophen-2-ylmethyl)thiourea | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
thiocyanic acid [2-(1-naphthalenyl)-2-oxoethyl] ester | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
mcb-613 | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
4-(benzenesulfonamido)-N-(5-ethyl-1,3,4-thiadiazol-2-yl)benzamide | Homo sapiens (human) | Potency | 4.4668 | 1 | 0 |
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-dibenzofuransulfonamide | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
N-(2-fluorophenyl)-4-methoxy-2,5-dimethylbenzenesulfonamide | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
N-[[[(2,4-dichlorophenyl)-oxomethyl]hydrazo]-sulfanylidenemethyl]-2,2-dimethylpropanamide | Homo sapiens (human) | Potency | 5.0119 | 1 | 0 |
1-[4-(5-fluoro-1,2-benzoxazol-3-yl)-1-piperidinyl]-2-[(4-methyl-2-quinolinyl)thio]ethanone | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
4-methyl-N-(2-phenylphenyl)-3-(phenylsulfamoyl)benzamide | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
2-[2-[[3-(1,3-benzoxazol-2-yl)anilino]-oxomethyl]phenyl]benzoic acid | Homo sapiens (human) | Potency | 3.9811 | 1 | 0 |
1,3-dimethyl-5-[[2-[2-(4-nitrophenoxy)ethoxy]phenyl]methylidene]-1,3-diazinane-2,4,6-trione | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
N-[[(1-oxo-3-phenylpropyl)hydrazo]-sulfanylidenemethyl]pentanamide | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
N-[4-[(4,6-dimethyl-2-pyrimidinyl)sulfamoyl]phenyl]-2-phenyl-4-quinolinecarboxamide | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
2-(4,6-dimethyl-2-pyrimidinyl)-4-[(4-fluorophenyl)thio]-5-methyl-3-pyrazolamine | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
7-methyl-3-(phenylhydrazo)-1,5-benzodiazepin-2-one | Homo sapiens (human) | Potency | 3.5481 | 1 | 0 |
3-(4-methoxyphenyl)-N-[[[oxo(pyridin-4-yl)methyl]hydrazo]-sulfanylidenemethyl]-1-phenyl-4-pyrazolecarboxamide | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
2-[4-methyl-3-(1-piperidinylsulfonyl)phenyl]-1,2-benzothiazol-3-one | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
2-[(5-chloro-2-thiophenyl)sulfonylamino]-N-(2-methoxy-5-methylphenyl)benzamide | Homo sapiens (human) | Potency | 2.5119 | 1 | 0 |
2-[(1-oxido-2-pyridin-1-iumyl)thio]-1-(4-phenylphenyl)ethanone | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-quinolinecarboxamide | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
N-[5-[(2,6-dichlorophenyl)methylthio]-1,3,4-thiadiazol-2-yl]-5-methyl-2-pyrazinecarboxamide | Homo sapiens (human) | Potency | 22.3872 | 1 | 0 |
2-chloro-N-[4-[(3,4-dimethylphenyl)thio]phenyl]acetamide | Homo sapiens (human) | Potency | 11.2202 | 1 | 0 |
N-(4-tert-butyl-2-thiazolyl)-5-methyl-2-thiophenecarboxamide | Homo sapiens (human) | Potency | 19.9526 | 1 | 0 |
2-(2,3-dihydro-1H-inden-5-yloxy)-1-[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]ethanone | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
N-(2,3-dihydro-1H-inden-5-yl)-2-[[3-(2-fluorophenyl)-4-oxo-2-quinazolinyl]thio]acetamide | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
3-(1H-indol-3-yl)propanoic acid [2-[tert-butyl-(phenylmethyl)amino]-2-oxoethyl] ester | Homo sapiens (human) | Potency | 19.9526 | 1 | 0 |
7-[(4-acetylphenoxy)methyl]-5-thiazolo[3,2-a]pyrimidinone | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
5-chloro-2-mercaptobenzothiazole | Homo sapiens (human) | Potency | 14.1254 | 1 | 0 |
benzoylarginine nitroanilide | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
5-(2-chloroanilino)-3-oxo-4-isothiazolecarbonitrile | Homo sapiens (human) | Potency | 17.7828 | 1 | 0 |
mecysteine hydrochloride | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
tamoxifen citrate | Homo sapiens (human) | Potency | 17.7828 | 1 | 0 |
tamoxifen | Homo sapiens (human) | Potency | 18.3564 | 1 | 0 |
Betaine Aldehyde Chloride | Homo sapiens (human) | Potency | 28.1838 | 1 | 0 |
2-[1-[2-oxo-2-[(4-thiophen-2-ylphenyl)methylamino]ethyl]cyclohexyl]acetic acid | Homo sapiens (human) | Potency | 14.1254 | 1 | 0 |
4-(5-methyl-3-phenylisoxazol-4-yl)pyrimidin-2-amine | Homo sapiens (human) | Potency | 3.5481 | 1 | 0 |
N-(3-chlorophenyl)-2-[[2-(2-pyridinyl)-2,3-dihydro-1,3,4-thiadiazol-5-yl]thio]acetamide | Homo sapiens (human) | Potency | 8.9125 | 1 | 0 |
3-[[(2,4-dichlorophenyl)methylthio]methyl]-4-propan-2-yl-1H-1,2,4-triazole-5-thione | Homo sapiens (human) | Potency | 22.3872 | 1 | 0 |
stattic | Homo sapiens (human) | Potency | 20.5962 | 1 | 0 |
6-methoxy-3-nitro-2-(phenylsulfonyl)pyridine | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
3-[1-(2,4-dichlorophenyl)sulfonyl-2-pyrrolidinyl]pyridine | Homo sapiens (human) | Potency | 22.3872 | 1 | 0 |
N'-(4-tert-butyl-2-thiazolyl)-4-chlorobenzohydrazide | Homo sapiens (human) | Potency | 17.7828 | 1 | 0 |
6-methyl-2-[[(4-methylanilino)-oxomethyl]amino]-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxylic acid ethyl ester | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
2-[[(5-tert-butyl-2-methyl-3-furanyl)-oxomethyl]amino]-4,5-dimethoxybenzoic acid methyl ester | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
2-[4-(2-methylpropyl)phenyl]propanoic acid [2-(1H-indol-3-yl)-2-oxoethyl] ester | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
2-(4-pentylphenyl)acetic acid | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
1-(4-bromophenyl)-3-(diethylamino)pyrrolidine-2,5-dione | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
1-hexadecyl-3-methylimidazolium bromide | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
1-(3,5-dichlorophenyl)-3-(4-morpholinyl)pyrrolidine-2,5-dione | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
nemadipine-a | Homo sapiens (human) | Potency | 29.0929 | 1 | 0 |
1-[(4-chlorophenyl)-oxomethyl]-5-hydroxy-5-phenyl-4H-pyrazole-3-carboxylic acid methyl ester | Homo sapiens (human) | Potency | 19.9526 | 1 | 0 |
2-[[1-(4-ethoxyphenyl)-2,5-dioxo-3-pyrrolidinyl]amino]acetonitrile | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
4-[3-[[(2,5-dichloroanilino)-methyliminomethyl]thio]-2,5-dioxo-1-pyrrolidinyl]benzoic acid methyl ester | Homo sapiens (human) | Potency | 17.7828 | 1 | 0 |
1-[8-chloro-4-(1-naphthalenyl)-3,3a,4,9b-tetrahydrocyclopenta[c]quinolin-5-yl]ethanone | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
2-[4-(3,4-dihydro-1H-isoquinolin-2-yl)-4-oxobutyl]benzo[de]isoquinoline-1,3-dione | Homo sapiens (human) | Potency | 17.7828 | 1 | 0 |
N-(1-butyl-2-benzimidazolyl)cyclohexanecarboxamide | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
2-[(4-chlorophenyl)thio]-N-[4-[(2,4-dimethylphenyl)sulfamoyl]phenyl]propanamide | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
5-[(3-ethoxycarbonyl-5,6-dihydro-4H-cyclopenta[b]thiophen-2-yl)amino]-5-oxopentanoic acid | Homo sapiens (human) | Potency | 3.1623 | 1 | 0 |
3-chloro-N-[3-(1-imidazolyl)propyl]-6-nitro-1-benzothiophene-2-carboxamide | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
2-[[1-(4-methoxy-2-nitrophenyl)-2,5-dioxo-3-pyrrolidinyl]thio]benzoic acid | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
4-[hydroxy(diphenyl)methyl]-N-(2-phenylethyl)-1-piperidinecarbothioamide | Homo sapiens (human) | Potency | 17.7828 | 1 | 0 |
2-[[[4-[[2-(4-chloro-2-methylphenoxy)-1-oxopropyl]amino]phenyl]-oxomethyl]amino]benzoic acid | Homo sapiens (human) | Potency | 22.3872 | 1 | 0 |
N-(5-chloro-2-hydroxyphenyl)-2-ethoxybenzamide | Homo sapiens (human) | Potency | 11.2202 | 1 | 0 |
4-[[2-(4-ethyl-3-oxo-2-morpholinyl)-1-oxoethyl]amino]benzoic acid ethyl ester | Homo sapiens (human) | Potency | 17.7828 | 1 | 0 |
3-(5-chloro-2-hydroxyphenyl)-3-phenyl-N-[(4-propan-2-yloxyphenyl)methyl]propanamide | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
5-chloro-7-[3-pyridinyl-(2-pyridinylamino)methyl]-8-quinolinol | Homo sapiens (human) | Potency | 17.7828 | 1 | 0 |
N-(3-carbamoyl-5-propyl-2-thiophenyl)-2-oxolanecarboxamide | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
[3-(2-hydroxyphenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]-phenylmethanone | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
4-[[3-[(4-chlorophenyl)sulfonylamino]-2-quinoxalinyl]amino]-1-piperidinecarboxylic acid ethyl ester | Homo sapiens (human) | Potency | 14.1254 | 1 | 0 |
1-(4-methoxy-2-nitrophenyl)-4-(5,6,7,8-tetrahydronaphthalen-2-ylsulfonyl)piperazine | Homo sapiens (human) | Potency | 3.9811 | 1 | 0 |
cb 7969312 | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
1-(2-methoxy-5-methylphenyl)-5-(2-oxanylmethylthio)tetrazole | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
2-[(3-butan-2-yl-4-oxo-2-quinazolinyl)thio]propanenitrile | Homo sapiens (human) | Potency | 33.5520 | 1 | 0 |
2-[2-(2,5-dimethyl-1-phenyl-3-pyrrolyl)-2-oxoethyl]-3a,4,7,7a-tetrahydroisoindole-1,3-dione | Homo sapiens (human) | Potency | 0.5623 | 1 | 0 |
2-acetylpyridine-(4-phenylthiosemicarbazone) | Homo sapiens (human) | Potency | 7.0795 | 1 | 0 |
LSM-1318 | Homo sapiens (human) | Potency | 10.3298 | 1 | 0 |
zuclomifene citrate | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
omephine | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
N-[[2-(4-chlorophenyl)-1,3-dioxo-7,7a-dihydro-3aH-octahydro-1H-4,7-epoxyisoindol-4-yl]methyl]benzenesulfonamide | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
(3-bromophenyl)-[5-(4-bromophenyl)-3-ethyl-5-hydroxy-4H-pyrazol-1-yl]methanone | Homo sapiens (human) | Potency | 14.1254 | 1 | 0 |
2-[(3-cyano-4,6-diphenyl-2-pyridinyl)thio]-3-methylbutanoic acid | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
N-[[5-[(4-chlorophenyl)methylthio]-4-phenyl-1,2,4-triazol-3-yl]methyl]-4-ethoxyaniline | Homo sapiens (human) | Potency | 22.3872 | 1 | 0 |
3-nitro-N-[(1-oxopentylhydrazo)-sulfanylidenemethyl]benzamide | Homo sapiens (human) | Potency | 17.7828 | 1 | 0 |
1,6-dimethyl-3-propylpyrimido[5,4-e][1,2,4]triazine-5,7-dione | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
[4-(2,7-dimethyl-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-4-yl)-1-piperazinyl]-(2-furanyl)methanone | Homo sapiens (human) | Potency | 11.2202 | 1 | 0 |
2-chloro-N-[1-[oxo(10-phenothiazinyl)methyl]-4-piperidinyl]benzamide | Homo sapiens (human) | Potency | 19.9526 | 1 | 0 |
N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]-2-[[3-(2-methoxyphenyl)-4-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-2-yl]thio]acetamide | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
5-ethyl-N-[2-(2-phenyl-4-thiazolyl)ethyl]-2-thiophenesulfonamide | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
4-[[2-(3-ethylanilino)-3,4-dioxo-1-cyclobutenyl]amino]-1-piperidinecarboxylic acid ethyl ester | Homo sapiens (human) | Potency | 6.3096 | 1 | 0 |
2-(3-phenyl-1-indazolyl)acetic acid methyl ester | Homo sapiens (human) | Potency | 0.3162 | 1 | 0 |
5-(4-chlorophenyl)-N-(2-furanylmethyl)-3-isoxazolecarboxamide | Homo sapiens (human) | Potency | 0.5623 | 1 | 0 |
5-nitro-2-thiophenecarboxylic acid [2-oxo-2-(1-phenylethylamino)ethyl] ester | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
2-phenoxy-N-[5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,4-oxadiazol-2-yl]acetamide | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
1-(3,4-dichlorophenyl)-3-[1-(4-morpholinyl)-1-phenylpropan-2-yl]urea | Homo sapiens (human) | Potency | 14.1254 | 1 | 0 |
ro 41-0960 | Homo sapiens (human) | Potency | 20.5962 | 1 | 0 |
4-(3,4-dihydro-2H-quinolin-1-ylsulfonyl)-N-(5-ethyl-1,3,4-oxadiazol-2-yl)benzamide | Homo sapiens (human) | Potency | 3.1623 | 1 | 0 |
1-(4-methoxyphenyl)-3-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)pyrrolidine-2,5-dione | Homo sapiens (human) | Potency | 2.8184 | 1 | 0 |
N-(4-fluorophenyl)-2-(3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-yl)-2-oxoacetamide | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
7-(5-bromo-2-fluorophenyl)-5-(4-bromophenyl)-1,7-dihydro-[1,2,4]triazolo[1,5-a]pyrimidine | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
N-[5-(2,3-dihydro-1,4-dioxin-5-yl)-1,3,4-oxadiazol-2-yl]-5-nitro-2-thiophenecarboxamide | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
sb 242084 | Homo sapiens (human) | Potency | 29.0929 | 1 | 0 |
2-[8-bromo-7-[(2-chlorophenyl)methyl]-3-methyl-2,6-dioxo-1-purinyl]acetic acid methyl ester | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
2-[4-[3-(4-methoxyphenyl)-1H-pyrazol-5-yl]-1-piperidinyl]-3-nitropyridine | Homo sapiens (human) | Potency | 14.1254 | 1 | 0 |
3-methyl-N-[[[(4-nitrophenyl)-oxomethyl]hydrazo]-sulfanylidenemethyl]butanamide | Homo sapiens (human) | Potency | 3.9811 | 1 | 0 |
N-[2-(3-methyl-1-oxobutyl)-3-oxo-1,2,4-thiadiazol-5-yl]benzamide | Homo sapiens (human) | Potency | 22.3872 | 1 | 0 |
1-(4-chlorophenyl)-3-[2-(2-furanylmethyl)cyclohexyl]urea | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
2-(1H-benzimidazol-2-yl)-5-methyl-4-(phenylmethyl)-4H-pyrazol-3-one | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
1-(2-fluorophenyl)-3-(N-(phenylmethyl)anilino)thiourea | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
1-(3,3-dimethylbutan-2-yl)-3-[3-(trifluoromethyl)phenyl]thiourea | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
2-[(2,2-dichloro-3,3-dimethylcyclopropyl)methylthio]-1H-benzimidazole | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
3-chloro-N-[5-(3-pyridinyl)-1,3,4-oxadiazol-2-yl]benzamide | Homo sapiens (human) | Potency | 17.7828 | 1 | 0 |
N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-4-[(3-methyl-1-piperidinyl)sulfonyl]benzamide | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
N-[4-[(1,2-dimethyl-5-indolyl)methylsulfamoyl]phenyl]acetamide | Homo sapiens (human) | Potency | 5.0119 | 1 | 0 |
2-chloro-N-[5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,4-oxadiazol-2-yl]benzamide | Homo sapiens (human) | Potency | 3.5481 | 1 | 0 |
4-chloro-N-(1,3,4-thiadiazol-2-yl)-5-dithiazolimine | Homo sapiens (human) | Potency | 19.9526 | 1 | 0 |
LSM-16446 | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
2,4-dichloro-N-[5-(5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,4-oxadiazol-2-yl]benzamide | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
5-nitro-2-thiophenecarboxylic acid [2-oxo-2-[(phenylmethyl)amino]ethyl] ester | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
1-(2,4-difluorophenyl)-3-[4-(2-pyridinyl)-2-thiazolyl]urea | Homo sapiens (human) | Potency | 8.9125 | 1 | 0 |
3-[(2,6-dimethyl-4-morpholinyl)sulfonyl]-N-(5-methyl-2-thiazolyl)benzamide | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
2-[(2-chlorophenyl)methoxy]-N-(4,5-dihydrothiazol-2-yl)benzamide | Homo sapiens (human) | Potency | 1.5849 | 1 | 0 |
5'-bromo-2'-spiro[1,2-dihydro-4,1,2-benzoxadiazine-3,3'-1H-indole]one | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
1-(3,4-dichlorophenyl)-3-(1,3,5-trimethyl-4-pyrazolyl)urea | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
N-[[[2-(2-naphthalenyloxy)-1-oxopropyl]hydrazo]-sulfanylidenemethyl]-2-furancarboxamide | Homo sapiens (human) | Potency | 7.0795 | 1 | 0 |
LSM-4833 | Homo sapiens (human) | Potency | 22.3872 | 1 | 0 |
N-(4-Nitro-1,2,5-oxadiazol-3-yl)-2-pyridin-2-ylsulfanylacetamide | Homo sapiens (human) | Potency | 11.2202 | 1 | 0 |
diclofenac sodium | Homo sapiens (human) | Potency | 25.9207 | 1 | 0 |
N,N-dimethyl-3-(3-oxo-1,2-benzothiazol-2-yl)benzenesulfonamide | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
2-[(1-methyl-3-indolyl)thio]-1-(4-phenyl-1-piperazinyl)ethanone | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
5-[(2,4-dichlorophenoxy)methyl]-N-[3,5-dimethyl-1-[(2,3,4,5,6-pentafluorophenyl)methyl]-4-pyrazolyl]-2-furancarboxamide | Homo sapiens (human) | Potency | 22.3872 | 1 | 0 |
4,5,6,7-tetrabromobenzimidazole | Homo sapiens (human) | Potency | 3.2643 | 1 | 0 |
4-[[[[2-(3-pyridinyl)-1-piperidinyl]amino]-sulfanylidenemethyl]amino]benzoic acid methyl ester | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
sib 1757 | Homo sapiens (human) | Potency | 12.8578 | 1 | 0 |
dibutyl maleate | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
morusin | Homo sapiens (human) | Potency | 17.7828 | 1 | 0 |
trans-2,3',4,5'-tetrahydroxystilbene | Homo sapiens (human) | Potency | 14.1254 | 1 | 0 |
Pinosylvin methyl ether | Homo sapiens (human) | Potency | 28.1838 | 1 | 0 |
caffeic acid phenethyl ester | Homo sapiens (human) | Potency | 4.1679 | 1 | 0 |
Licarin A | Homo sapiens (human) | Potency | 7.9433 | 1 | 0 |
tectochrysin | Homo sapiens (human) | Potency | 6.3096 | 1 | 0 |
n-oleoyldopamine | Homo sapiens (human) | Potency | 30.3578 | 1 | 0 |
perhexiline maleate | Homo sapiens (human) | Potency | 4.4668 | 1 | 0 |
sirolimus | Homo sapiens (human) | Potency | 3.9811 | 1 | 0 |
as 604850 | Homo sapiens (human) | Potency | 8.1995 | 1 | 0 |
2-[[2-(3,4-dimethoxyphenyl)-5-methyl-4-oxazolyl]methylsulfinyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
N,N-dicyclohexyl-5-propyl-3-isoxazolecarboxamide | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
3-(3,4-dimethoxyphenyl)-5,7-dihydroxy-2-methyl-1-benzopyran-4-one | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
N-(1,3-benzodioxol-5-yl)-2-(5-methyl-2-furanyl)-3-imidazo[1,2-a]pyrazinamine | Homo sapiens (human) | Potency | 19.9526 | 1 | 0 |
2-[[cyclohexyl(oxo)methyl]amino]-3-thiophenecarboxamide | Homo sapiens (human) | Potency | 11.2202 | 1 | 0 |
esomeprazole magnesium | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
bornyl ferulate | Homo sapiens (human) | Potency | 22.3872 | 1 | 0 |
crenulatin coumarin | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
muromonab-cd3 | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
tyrphostin b44 | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
4-[4-(4-hydroxy-3-methoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-2-methoxyphenyl hexopyranoside | Homo sapiens (human) | Potency | 17.7828 | 1 | 0 |
bay 11-7082 | Homo sapiens (human) | Potency | 11.5821 | 1 | 0 |
bay 11-7085 | Homo sapiens (human) | Potency | 5.7141 | 1 | 0 |
2-(4-(dimethylamino)styryl)benzothiazole | Homo sapiens (human) | Potency | 11.5190 | 1 | 0 |
serratin | Homo sapiens (human) | Potency | 11.2202 | 1 | 0 |
guanabenz acetate | Homo sapiens (human) | Potency | 4.4668 | 1 | 0 |
methylbenzethonium chloride | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
quinaldine red | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
3,3'-diethylthiacarbocyanine iodide | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
chloride of pseudoisocyanine | Homo sapiens (human) | Potency | 11.2202 | 1 | 0 |
5233705 compound | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
10-hydroxy-3-methyl-8-pentyl-2,4-dihydro-1H-[1]benzopyrano[3,4-c]pyridin-5-one | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2h-pyran-2-one | Homo sapiens (human) | Potency | 5.1735 | 1 | 0 |
Adenosine 5'-monophosphate monohydrate | Homo sapiens (human) | Potency | 3.1623 | 1 | 0 |
enclomiphene citrate | Homo sapiens (human) | Potency | 14.1254 | 1 | 0 |
lasalocid sodium | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
sclerotiorin | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
4-hydroxyderricin | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
su 4312 | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
l-165041 | Homo sapiens (human) | Potency | 22.4709 | 1 | 0 |
cycloheximide | Homo sapiens (human) | Potency | 3.5481 | 1 | 0 |
granisetron hydrochloride | Homo sapiens (human) | Potency | 5.0119 | 1 | 0 |
edelfosine | Homo sapiens (human) | Potency | 29.0929 | 1 | 0 |
altenusin | Homo sapiens (human) | Potency | 14.1254 | 1 | 0 |
13-epi-sclareol | Homo sapiens (human) | Potency | 19.9526 | 1 | 0 |
N-[(2-chlorophenyl)methyl]-2-[7-oxo-3-(phenylmethyl)-6-triazolo[4,5-d]pyrimidinyl]acetamide | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
N-[4-(1-adamantylsulfamoyl)phenyl]-4-bromo-1-methyl-3-pyrazolecarboxamide | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
chlorhexidine | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
aldicarb sulfoxide | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
17-cyclopropylmethyl-6,7-didehydro-4,5-epoxy-5'-guanidinyl-3,14-dihydroxyindolo(2',3'-6,7)morphinan | Homo sapiens (human) | Potency | 5.8048 | 1 | 0 |
lissamine rhodamine b | Homo sapiens (human) | Potency | 7.9433 | 1 | 0 |
NNC 55-0396 (free base) | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
levodopa methyl ester hydrochloride | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
teferin | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
((2-n-butyl-6,7-dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1h-inden-5-yl)oxy)acetic acid, (+)-isomer | Homo sapiens (human) | Potency | 19.3736 | 1 | 0 |
uncarine c | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
(5R)-9-bromo-5-phenyl-3-prop-2-enyl-1,2,4,5-tetrahydro-3-benzazepine-7,8-diol | Homo sapiens (human) | Potency | 23.1093 | 1 | 0 |
2-(4-methoxyphenyl)-1,2-benzothiazol-3-one | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
2-(4-chlorophenyl)-1,2-benzothiazol-3-one | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
N(2)-([biphenyl]-4-ylsulfonyl)-N-hydroxy-N(2)-isopropoxy-D-valinamide | Homo sapiens (human) | Potency | 16.3601 | 1 | 0 |
glabrol | Homo sapiens (human) | Potency | 22.3872 | 1 | 0 |
N-[(1,3-dioxo-2-phenyl-7,7a-dihydro-3aH-octahydro-1H-4,7-epoxyisoindol-4-yl)methyl]-4-methylbenzenesulfonamide | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
2-(2,1,3-benzothiadiazol-4-ylsulfonyl)-5-(4-bromophenyl)-3-pyrazolamine | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
b 015 | Homo sapiens (human) | Potency | 6.5131 | 1 | 0 |
calcimycin | Homo sapiens (human) | Potency | 6.5131 | 1 | 0 |
(2R,3S)-EHNA hydrochloride | Homo sapiens (human) | Potency | 3.5481 | 1 | 0 |
4-methylpyrazole monohydrochloride | Homo sapiens (human) | Potency | 19.9526 | 1 | 0 |
1-(4-fluorophenyl)-3-[[2-(4-methylphenyl)-1,3-dioxo-7,7a-dihydro-3aH-octahydro-1H-4,7-epoxyisoindol-4-yl]methyl]thiourea | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
1-(4-methylphenyl)-3-[[2-(4-methylphenyl)-1,3-dioxo-7,7a-dihydro-3aH-octahydro-1H-4,7-epoxyisoindol-4-yl]methyl]thiourea | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
1-(3-chlorophenyl)-3-[[2-(4-methylphenyl)-1,3-dioxo-7,7a-dihydro-3aH-octahydro-1H-4,7-epoxyisoindol-4-yl]methyl]thiourea | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
chlorhexidine hydrochloride | Homo sapiens (human) | Potency | 28.1838 | 1 | 0 |
(R)-Bitalin A | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
2-(3-chlorophenyl)-1,2-benzothiazol-3-one | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
[3-methyl-4-(3-methylphenyl)-1-piperazinyl]-[1-(7,8,9,10-tetrahydro-6H-purino[9,8-a]azepin-4-yl)-4-piperidinyl]methanone | Homo sapiens (human) | Potency | 28.1838 | 1 | 0 |
tannins | Homo sapiens (human) | Potency | 11.2202 | 1 | 0 |
N-[2-(3,4-dimethoxyphenyl)ethyl]-2-[3-(4-fluorophenyl)-2,4-dioxo-1-thieno[3,2-d]pyrimidinyl]acetamide | Homo sapiens (human) | Potency | 0.5623 | 1 | 0 |
1-[(1-ethyl-3,4-dihydro-2H-quinolin-6-yl)methyl]-3-(3-methoxyphenyl)-1-[2-(4-morpholinyl)ethyl]thiourea | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
N-[[2-(4-methylphenyl)-1,3-dioxo-7,7a-dihydro-3aH-octahydro-1H-4,7-epoxyisoindol-4-yl]methyl]-4-phenyl-1-piperazinecarbothioamide | Homo sapiens (human) | Potency | 11.2202 | 1 | 0 |
[5-(4-bromophenyl)-3-(2-hydroxyphenyl)-3,4-dihydropyrazol-2-yl]-pyridin-4-ylmethanone | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
xi-3-Hydroxy-5-phenylpentanoic acid O-beta-D-Glucopyranoside | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
(5S)-1-(4-cyclohexylbutyl)-5-phenyl-4,5-dihydroimidazol-2-amine | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
(5R)-1-[2-[3,5-bis(trifluoromethyl)phenyl]ethyl]-5-butyl-4,5-dihydroimidazol-2-amine | Homo sapiens (human) | Potency | 14.1254 | 1 | 0 |
thimerosal | Homo sapiens (human) | Potency | 0.7079 | 1 | 0 |
2-[[[4-[(4-chloroanilino)-oxomethyl]-1H-imidazol-5-yl]-oxomethyl]amino]acetic acid tert-butyl ester | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
1-(2,3-Dihydro-1,4-benzodioxin-3-ylmethyl)-5-methoxy-isatin | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
5-[[4-(4-acetylphenyl)-1-piperazinyl]sulfonyl]-1,3-dihydroindol-2-one | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
5-fluoro-2-phenyl-1,2-benzothiazol-3-one | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
2-(2-fluorophenyl)-1,2-benzothiazol-3-one | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
2-(4-fluorophenyl)-1,2-benzothiazol-3-one | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
3-[1-[[1-(4-chlorophenyl)cyclopropyl]-oxomethyl]-4-piperidinyl]-5-phenyl-1,3,4-oxadiazol-2-one | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
acid blue 129 | Homo sapiens (human) | Potency | 22.3872 | 1 | 0 |
sodium 2,6-dichloroindophenol | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
2-[(6-chloro-3-pyridinyl)sulfonylamino]-N-[(4-methylphenyl)methyl]benzamide | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
4-[[3-(4-chlorophenyl)-5-isoxazolyl]methyl]-1-[(2-methylpropan-2-yl)oxy-oxomethyl]-4-piperidinecarboxylic acid | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
4-chloro-N-(5-methyl-1,3,4-oxadiazol-2-yl)-5-dithiazolimine | Homo sapiens (human) | Potency | 3.1623 | 1 | 0 |
4-[3-(3-methylphenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide | Homo sapiens (human) | Potency | 22.3872 | 1 | 0 |
4-[3-(3-bromophenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide | Homo sapiens (human) | Potency | 22.3872 | 1 | 0 |
2-[5-[(3,4-dichlorophenyl)methylthio]-4-(2-furanylmethyl)-1,2,4-triazol-3-yl]pyridine | Homo sapiens (human) | Potency | 5.6234 | 1 | 0 |
1-(3-aminopropyl)-3-[3-[(5-bromo-2-pyridinyl)-[(4-chlorophenyl)methyl]amino]propyl]thiourea | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
1-[4-[(5-bromo-2-pyridinyl)-[(4-chlorophenyl)methyl]amino]butyl]-3-[3-(1H-imidazol-5-yl)propyl]thiourea | Homo sapiens (human) | Potency | 19.9526 | 1 | 0 |
sphaeropsidin a | Homo sapiens (human) | Potency | 1.9953 | 1 | 0 |
1-butyl-4-hydroxy-N-(3-methyl-2-pyridinyl)-2-oxo-3-quinolinecarboxamide | Homo sapiens (human) | Potency | 19.9526 | 1 | 0 |
piroxicam | Homo sapiens (human) | Potency | 5.8048 | 1 | 0 |
4,7-Dihydroxy-2H-1-benzopyran-2-one | Homo sapiens (human) | Potency | 22.3872 | 1 | 0 |
N-(1H-benzimidazol-2-yl)-1-ethyl-4-hydroxy-2-oxo-3-quinolinecarboxamide | Homo sapiens (human) | Potency | 19.9526 | 1 | 0 |
a 1062 | Homo sapiens (human) | Potency | 7.9433 | 1 | 0 |
folic acid | Homo sapiens (human) | Potency | 3.9811 | 1 | 0 |
1-hydroxyphenazine | Homo sapiens (human) | Potency | 22.3872 | 1 | 0 |
2-pyridin-4-yl-1H-quinazolin-4-one | Homo sapiens (human) | Potency | 22.3872 | 1 | 0 |
tegaserod maleate | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
ag-879 | Homo sapiens (human) | Potency | 11.5821 | 1 | 0 |
N-[(4-oxo-1H-quinazolin-2-yl)methyl]-N-(2-phenylethyl)butanamide | Homo sapiens (human) | Potency | 14.1254 | 1 | 0 |
2-[(7-methoxy-4-methyl-2-quinazolinyl)amino]-5,6-dimethyl-1H-pyrimidin-4-one | Homo sapiens (human) | Potency | 35.4813 | 1 | 0 |
5-(4-chlorophenyl)-3-(4-nitrophenyl)-1H-pyrazole | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
Target | Category | Definition |
negative regulation of transcription by RNA polymerase II | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of transcription mediated by RNA polymerase II. [GOC:go_curators, GOC:txnOH] |
microglial cell activation | biological process | The change in morphology and behavior of a microglial cell resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor. [GOC:mgi_curators, PMID:10626665, PMID:10695728, PMID:12580336, PMID:9893949] |
positive regulation of receptor recycling | biological process | Any process that activates or increases the frequency, rate or extent of receptor recycling. [GOC:add] |
positive regulation of neurotransmitter secretion | biological process | Any process that activates or increases the frequency, rate or extent of the regulated release of a neurotransmitter. [GOC:hjd] |
negative regulation of protein kinase activity | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of protein kinase activity. [GOC:go_curators] |
fatty acid metabolic process | biological process | The chemical reactions and pathways involving fatty acids, aliphatic monocarboxylic acids liberated from naturally occurring fats and oils by hydrolysis. [ISBN:0198547684] |
neutral lipid metabolic process | biological process | The chemical reactions and pathways involving neutral lipids, lipids only soluble in solvents of very low polarity. [ISBN:0198547684] |
phospholipid metabolic process | biological process | The chemical reactions and pathways involving phospholipids, any lipid containing phosphoric acid as a mono- or diester. [ISBN:0198506732] |
activation of cysteine-type endopeptidase activity involved in apoptotic process | biological process | Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process. [GOC:al, GOC:dph, GOC:jl, GOC:mtg_apoptosis, GOC:tb, PMID:14744432, PMID:18328827, Wikipedia:Caspase] |
mitochondrial membrane organization | biological process | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a mitochondrial membrane, either of the lipid bilayer surrounding a mitochondrion. [GOC:ai, GOC:dph, GOC:jl, GOC:mah] |
adult locomotory behavior | biological process | Locomotory behavior in a fully developed and mature organism. [GOC:ai] |
response to xenobiotic stimulus | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a xenobiotic, a compound foreign to the organim exposed to it. It may be synthesized by another organism (like ampicilin) or it can be a synthetic chemical. [GOC:jl, GOC:krc] |
response to iron(II) ion | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an iron(II) ion stimulus. [GOC:sm] |
regulation of phospholipase activity | biological process | Any process that modulates the frequency, rate or extent of phospholipase activity, the hydrolysis of a phospholipid. [GOC:BHF, GOC:dph, GOC:tb] |
negative regulation of platelet-derived growth factor receptor signaling pathway | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of the platelet-derived growth factor receptor signaling pathway. [GOC:dph, GOC:hjd, GOC:tb] |
regulation of glutamate secretion | biological process | Any process that modulates the frequency, rate or extent of the controlled release of glutamate. [GOC:ef] |
regulation of dopamine secretion | biological process | Any process that modulates the frequency, rate or extent of the regulated release of dopamine. [GOC:ef] |
synaptic vesicle exocytosis | biological process | Fusion of intracellular membrane-bounded vesicles with the pre-synaptic membrane of the neuronal cell resulting in release of neurotransmitter into the synaptic cleft. [GOC:jid, GOC:lmg] |
synaptic vesicle priming | biological process | A process that converts synaptic vesicles to a state of competence for calcium triggered fusion with the active zone membrane by bringing the two membranes into very close proximity. Priming typically (but not always) occurs after docking (Jahn and Fasshauer, 2012). Primed vesicles are also capable of spontaneously fusing with the active zone membrane. [GOC:mah, PMID:15217342, PMID:23060190] |
regulation of transmembrane transporter activity | biological process | Any process that modulates the frequency, rate or extent of transmembrane transporter activity. [GOC:dph, GOC:mtg_cardio, GOC:mtg_transport] |
negative regulation of microtubule polymerization | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of microtubule polymerization. [GOC:mah] |
receptor internalization | biological process | A receptor-mediated endocytosis process that results in the movement of receptors from the plasma membrane to the inside of the cell. The process begins when cell surface receptors are monoubiquitinated following ligand-induced activation. Receptors are subsequently taken up into endocytic vesicles from where they are either targeted to the lysosome or vacuole for degradation or recycled back to the plasma membrane. [GOC:bf, GOC:mah, GOC:signaling, PMID:15006537, PMID:19643732] |
protein destabilization | biological process | Any process that decreases the stability of a protein, making it more vulnerable to degradative processes or aggregation. [GOC:mah] |
response to magnesium ion | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a magnesium ion stimulus. [GOC:mah] |
negative regulation of transporter activity | biological process | Any process that stops or reduces the activity of a transporter. [GOC:mah] |
response to lipopolysaccharide | biological process | Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. [GOC:add, ISBN:0721601464] |
negative regulation of monooxygenase activity | biological process | Any process that stops or reduces the activity of a monooxygenase. [GOC:mah] |
positive regulation of peptidyl-serine phosphorylation | biological process | Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-serine. [GOC:mah] |
response to type II interferon | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interferon-gamma stimulus. Interferon-gamma is also known as type II interferon. [GOC:add, ISBN:0126896631, PMID:15546383] |
cellular response to oxidative stress | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals. [GOC:mah] |
SNARE complex assembly | biological process | The aggregation, arrangement and bonding together of a set of components to form a SNARE complex, a protein complex involved in membrane fusion; a stable ternary complex consisting of a four-helix bundle, usually formed from one R-SNARE and three Q-SNAREs with an ionic layer sandwiched between hydrophobic layers. [GOC:rb, PMID:10872468] |
positive regulation of SNARE complex assembly | biological process | Any process that increases the frequency, rate or extent of assembly of the SNARE complex. The SNARE complex is a protein complex involved in membrane fusion; a stable ternary complex consisting of a four-helix bundle, usually formed from one R-SNARE and three Q-SNAREs with an ionic layer sandwiched between hydrophobic layers. [GOC:rb] |
regulation of locomotion | biological process | Any process that modulates the frequency, rate or extent of locomotion of a cell or organism. [GOC:ems] |
dopamine biosynthetic process | biological process | The chemical reactions and pathways resulting in the formation of dopamine, a catecholamine neurotransmitter and a metabolic precursor of noradrenaline and adrenaline. [GOC:jl, ISBN:0198506732] |
mitochondrial ATP synthesis coupled electron transport | biological process | The transfer of electrons through a series of electron donors and acceptors, generating energy that is ultimately used for synthesis of ATP, as it occurs in the mitochondrial inner membrane or chloroplast thylakoid membrane. [GOC:mtg_sensu, ISBN:0716731363] |
regulation of macrophage activation | biological process | Any process that modulates the frequency or rate of macrophage activation. [GOC:jl] |
positive regulation of apoptotic process | biological process | Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process. [GOC:jl, GOC:mtg_apoptosis] |
negative regulation of apoptotic process | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. [GOC:jl, GOC:mtg_apoptosis] |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of a cysteine-type endopeptidase activity involved in the apoptotic process. [GOC:jl, GOC:mtg_apoptosis] |
negative regulation of neuron apoptotic process | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons. [GOC:go_curators, GOC:mtg_apoptosis] |
positive regulation of endocytosis | biological process | Any process that activates or increases the frequency, rate or extent of endocytosis. [GOC:go_curators] |
negative regulation of exocytosis | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of exocytosis. [GOC:go_curators] |
positive regulation of exocytosis | biological process | Any process that activates or increases the frequency, rate or extent of exocytosis. [GOC:go_curators] |
regulation of long-term neuronal synaptic plasticity | biological process | A process that modulates long-term neuronal synaptic plasticity, the ability of neuronal synapses to change long-term as circumstances require. Long-term neuronal synaptic plasticity generally involves increase or decrease in actual synapse numbers. [GOC:jid, PMID:11891290] |
synaptic vesicle endocytosis | biological process | A vesicle-mediated transport process, in which the synaptic vesicle membrane constituents are retrieved from the presynaptic membrane on the axon terminal after neurotransmitter secretion by exocytosis. Synaptic vesicle endocytosis can occur via clathrin-dependent and clathrin-independent mechanisms. [GOC:aruk, GOC:bc, GOC:jid, GOC:lmg, GOC:mah, PMID:20448150, PMID:26430111] |
synaptic vesicle transport | biological process | The directed movement of synaptic vesicles. [GOC:aruk, GOC:bc, GOC:jid, GOC:lmg, GOC:pr] |
positive regulation of inflammatory response | biological process | Any process that activates or increases the frequency, rate or extent of the inflammatory response. [GOC:ai] |
regulation of acyl-CoA biosynthetic process | biological process | Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of acyl-CoA. [GOC:ai] |
protein tetramerization | biological process | The formation of a protein tetramer, a macromolecular structure consisting of four noncovalently associated identical or nonidentical subunits. [GOC:ecd] |
positive regulation of release of sequestered calcium ion into cytosol | biological process | Any process that activates or increases the frequency, rate or extent of the release into the cytosolic compartment of calcium ions sequestered in the endoplasmic reticulum or mitochondria. [GOC:ai] |
neuron apoptotic process | biological process | Any apoptotic process in a neuron, the basic cellular unit of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the nervous system. [CL:0000540, GOC:mtg_apoptosis] |
dopamine uptake involved in synaptic transmission | biological process | The directed movement of dopamine into a presynaptic neuron or glial cell. In this context, dopamine is a catecholamine neurotransmitter and a metabolic precursor of noradrenaline and adrenaline. [GOC:ai] |
negative regulation of dopamine uptake involved in synaptic transmission | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of dopamine into a presynaptic neuron or glial cell. [GOC:ai] |
negative regulation of serotonin uptake | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of serotonin into a cell. [GOC:ai] |
regulation of norepinephrine uptake | biological process | Any process that modulates the frequency, rate or extent of the directed movement of the neurotransmitter norepinephrine into a cell. [GOC:ai] |
negative regulation of norepinephrine uptake | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of the directed movement of norepinephrine into a cell. [GOC:ai] |
excitatory postsynaptic potential | biological process | A process that leads to a temporary increase in postsynaptic potential due to the flow of positively charged ions into the postsynaptic cell. The flow of ions that causes an EPSP is an excitatory postsynaptic current (EPSC) and makes it easier for the neuron to fire an action potential. [GOC:dph, GOC:ef] |
long-term synaptic potentiation | biological process | A process that modulates synaptic plasticity such that synapses are changed resulting in the increase in the rate, or frequency of synaptic transmission at the synapse. [GOC:dgh, GOC:dph] |
positive regulation of inositol phosphate biosynthetic process | biological process | Any process that increases the rate, frequency or extent of inositol phosphate biosynthesis. Inositol phosphate biosynthetic processes are the chemical reactions and pathways resulting in the formation of an inositol phosphate, 1,2,3,4,5,6-cyclohexanehexol, with one or more phosphate groups attached. [GOC:dph, GOC:tb] |
negative regulation of thrombin-activated receptor signaling pathway | biological process | Any process that stops, prevents, or reduces the frequency, rate or extent of thrombin-activated receptor protein signaling pathway activity. A thrombin receptor signaling pathway is the series of molecular signals generated as a consequence of a thrombin-activated receptor binding to one of its physiological ligands. [GOC:mah] |
response to interleukin-1 | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus. [GOC:BHF, GOC:mah] |
cellular response to copper ion | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a copper ion stimulus. [GOC:mah] |
cellular response to epinephrine stimulus | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an epinephrine stimulus. Epinephrine is a catecholamine that has the formula C9H13NO3; it is secreted by the adrenal medulla to act as a hormone, and released by certain neurons to act as a neurotransmitter active in the central nervous system. [GOC:BHF, GOC:mah] |
positive regulation of protein serine/threonine kinase activity | biological process | Any process that increases the rate, frequency, or extent of protein serine/threonine kinase activity. [GOC:mah] |
supramolecular fiber organization | biological process | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a supramolecular fiber, a polymer consisting of an indefinite number of protein or protein complex subunits that have polymerised to form a fiber-shaped structure. [GOC:pr] |
negative regulation of mitochondrial electron transport, NADH to ubiquinone | biological process | Any process that stops, prevents or reduces the frequency, rate or extent of mitochondrial electron transport, NADH to ubiquinone. [GO_REF:0000058, GOC:dph, GOC:TermGenie, PMID:23530063] |
positive regulation of glutathione peroxidase activity | biological process | Any process that activates or increases the frequency, rate or extent of glutathione peroxidase activity. [GO_REF:0000059, GOC:bf, GOC:PARL, GOC:TermGenie, PMID:23507046] |
positive regulation of hydrogen peroxide catabolic process | biological process | Any process that activates or increases the frequency, rate or extent of hydrogen peroxide catabolic process. [GO_REF:0000058, GOC:bf, GOC:PARL, GOC:TermGenie, PMID:23507046] |
regulation of synaptic vesicle recycling | biological process | Any process that modulates the frequency, rate or extent of synaptic vesicle recycling. [GO_REF:0000058, GOC:pad, GOC:PARL, GOC:TermGenie, PMID:22745285] |
regulation of reactive oxygen species biosynthetic process | biological process | Any process that modulates the frequency, rate or extent of reactive oxygen species biosynthetic process. [GO_REF:0000058, GOC:bf, GOC:PARL, GOC:TermGenie, PMID:24252804] |
positive regulation of protein localization to cell periphery | biological process | Any process that activates or increases the frequency, rate or extent of protein localization to cell periphery. [GO_REF:0000058, GOC:TermGenie, PMID:18216290] |
negative regulation of chaperone-mediated autophagy | biological process | Any process that stops, prevents or reduces the frequency, rate or extent of chaperone-mediated autophagy. [GO_REF:0000058, GOC:pad, GOC:PARL, GOC:TermGenie, PMID:20176123] |
regulation of presynapse assembly | biological process | Any process that modulates the frequency, rate or extent of presynapse assembly. [GO_REF:0000058, GOC:bc, GOC:PARL, GOC:TermGenie, PMID:25533483] |
amyloid fibril formation | biological process | The generation of amyloid fibrils, insoluble fibrous protein aggregates exhibiting beta sheet structure, from proteins. [GOC:cvs, GOC:jj, GOC:ppm, GOC:sj, PMID:21148556, PMID:22817896, PMID:28937655, PMID:29654159] |
synapse organization | biological process | A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a synapse, the junction between a neuron and a target (neuron, muscle, or secretory cell). [GOC:ai, GOC:pr] |
chemical synaptic transmission | biological process | The vesicular release of classical neurotransmitter molecules from a presynapse, across a chemical synapse, the subsequent activation of neurotransmitter receptors at the postsynapse of a target cell (neuron, muscle, or secretory cell) and the effects of this activation on the postsynaptic membrane potential and ionic composition of the postsynaptic cytosol. This process encompasses both spontaneous and evoked release of neurotransmitter and all parts of synaptic vesicle exocytosis. Evoked transmission starts with the arrival of an action potential at the presynapse. [GOC:jl, MeSH:D009435] |